SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Novavax (NVAX)

NVAX RSS Feed
Add NVAX Price Alert      Hide Sticky   Hide Intro
Moderator: Atlanta1, beambe, Scotttrader80
Search This Board: 
Last Post: 8/17/2017 10:07:39 AM - Followers: 212 - Board type: Free - Posts Today: 0

ABOUT NOVAVAX:

Novavax, Inc. (Nasdaq: NVAX) is a clinical-stage biopharmaceutical company creating recombinant protein nanoparticle vaccines to address a broad range of infectious diseases. The company is developing a portfolio of vaccine candidates targeting seasonal and pandemic influenza (H5N1), a vaccine designed to protect children and the elderly against respiratory syncytial virus (RSV), rabies and other candidates. In addition, the company is developing its vaccine candidates for worldwide commercialization including:

Our world-class scientific team is using VLP technology to tackle influenza viruses – including avian strains that have the potential to cause a pandemic outbreak. Our team has created vaccine candidates that are in various phases of clinical testing designed to protect against various circulating strains of pandemic influenza including H1N1 and H5N1, as well as seasonal influenza. Our recombinant nanoparticle protein micelle technology targeted at RSV has been tested in various preclinical studies and has now advanced into clinical testing.

Our vision is to control the spread of infectious diseases by using a unique single-use manufacturing system that allows for the rapid mass production of recombinant protein nanoparticle vaccines. Our goal is to be able to rapidly deliver a customized vaccine in the midst of a declared pandemic.
 


MANAGEMENT TEAM:

President and Chief Executive Officer
Stanley C. Erck

Senior Vice President, Research and Development
Gregory M. Glenn, M.D.

Senior Vice President, Manufacturing and Process Development
Timothy J. Hahn, Ph.D.

Senior Vice President, Chief Financial Officer and Treasurer
Barclay A. "Buck" Phillips

Senior Vice President, Business Development
Russell P. "Rip" Wilson

Vice President, Regulatory Affairs
Amy B. Fix

Vice President, Chief Medical Officer
Louis F. Fries III, M.D.

Vice President, Manufacturing
Mervyn L. Hamer

Vice President, General Counsel and Corporate Secretary
John A. Herrmann III, J.D.

Vice President, Process Development
Erica Shane, Ph.D.

Vice President, Vaccine Development
Gale Smith, Ph.D.

Vice President, Clinical Operations
D. Nigel Thomas, Ph.D.

 

CLINICAL-STAGE PIPELINE:

Novavax’s clinical program includes vaccine candidates designed to address infectious diseases worldwide. Using innovative virus-like particle (VLP) and recombinant nanoparticle technology, as well as new and efficient manufacturing approaches, the company produces vaccine candidates to combat diseases, with the goal of allowing countries to better prepare for and more effectively respond to rapidly spreading infections. Our clinical pipeline is shown below.

 
ADJUVANT PIPELINE:

 

 
CHARTS:



 


LINKS:

http://www.novavax.com/
http://finance.yahoo.com/q/h?s=NVAX
http://www.novavax.com/download/File/Interphex.pdf
http://www.sec.gov/cgi-bin/browse-edgar?company=Novavax&CIK=&filenum=&State=&SIC=&owner=include&action=getcompany
http://www.wipo.int/pctdb/en/wo.jsp?WO=2008061243

 
NVAX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NVAX News: Securities Registration: Employee Benefit Plan (s-8) 08/09/2017 04:18:43 PM
NVAX News: Current Report Filing (8-k) 08/09/2017 04:07:01 PM
NVAX News: Quarterly Report (10-q) 08/08/2017 04:20:54 PM
NVAX News: Novavax Reports Second Quarter 2017 Financial Results 08/08/2017 04:05:39 PM
NVAX News: Novavax Reports Second Quarter 2017 Financial Results 08/08/2017 04:05:00 PM
PostSubject
#4727   Most people who frequent this board have been Scotttrader80 08/17/17 10:07:39 AM
#4726   Looks like it is starting the day no Gup80 08/16/17 08:13:30 AM
#4725   Its HTB once again...so the shorting increased to Gup80 08/15/17 04:55:04 PM
#4724   Worth the risk for investment.. Santo 08/15/17 01:50:19 PM
#4723   Its Not a POS stock, its a medical Scotttrader80 08/11/17 06:58:00 PM
#4722   Not likely this is a POS stock. N_D_K_Hey 08/11/17 04:27:47 PM
#4721   Yee just keep buying more. Though I am bobbodom 08/11/17 12:22:04 PM
#4720   Institutions keep increasing their shares. I'm going long. 10th_wonder 08/10/17 05:37:54 PM
#4719   No More Pricks-Quick Dissolvable Tablets is Set to corpus 08/10/17 04:32:55 PM
#4718   https://xi.onvista.de/typ3.chart?ID_NOTATION=3425190&TIME_SPAN=intraday&LEG beambe 08/10/17 03:12:57 PM
#4717   I bought today and will keep-no matter what beambe 08/10/17 02:57:53 PM
#4716   This stock is good for sure once the tpg 08/10/17 02:40:10 PM
#4715   http://novavax.com/download/images/content/sub/pipeline/pipeline%20update_3 beambe 08/10/17 12:18:06 PM
#4714   It will come so beambe 08/10/17 12:13:45 PM
#4713   Because it's been fluctuating to 1.07 every week bobbodom 08/10/17 10:39:21 AM
#4712   Because you saw the undervaluation and thought you declaes 08/10/17 10:26:04 AM
#4711   Please tell my why I bought this POS PARker1703 08/10/17 10:16:15 AM
#4710   Up up and away? Let's hope bobbodom 08/10/17 08:15:23 AM
#4709   Partnership before split, IMO bleu22 08/09/17 08:25:09 PM
#4707   Institutional buying cheap shares. JP Morgan increased! 10th_wonder 08/09/17 05:57:54 PM
#4706   They're trying to hit it again.. stay strong lol bobbodom 08/09/17 05:17:19 PM
#4705   Bs market stockwinner 08/09/17 04:07:30 PM
#4704   OTC Dirt? beambe 08/09/17 03:55:52 PM
#4703   Keep on churning bleu22 08/09/17 10:56:52 AM
#4702   good Volume beambe 08/09/17 10:18:34 AM
#4701   Looks like we finally bottom out, thanks to 10q.. Santo 08/09/17 09:57:49 AM
#4700   NVAX PreMarket: $1.07 +0.10 (10.17%) as of 8:00 AM Scotttrader80 08/09/17 08:16:10 AM
#4699   squeezzzzz shorty,,bleeedddd,,$5++++myop kingsransome 08/09/17 08:14:05 AM
#4698   Nvax might have a slow grind up. They 10th_wonder 08/09/17 07:40:41 AM
#4697   Gonna b interesting IMO bleu22 08/09/17 07:24:58 AM
#4696   We should climb up back to old golden days stockwinner 08/09/17 12:31:49 AM
#4695   CEO said NVAX ahead of GSK VAC BY bleu22 08/08/17 07:46:45 PM
#4694   1.06 -1.07 AH up 10% declaes 08/08/17 05:09:08 PM
#4693   Hopefully we SQEEZE HIS AS? bleu22 08/08/17 05:03:51 PM
#4692   I hope AF is listening, he can learn declaes 08/08/17 04:58:55 PM
#4691   I'm happy with the news :) Santo 08/08/17 04:39:55 PM
#4690   if the world is still here in the dirtydozen911 08/08/17 04:28:20 PM
#4689   numbers sound pretty good. Flu vaccine results the gipper 08/08/17 04:27:59 PM
#4688   Same here bleu22 08/08/17 04:25:21 PM
#4687   Rev up 169%.... i like what i ser declaes 08/08/17 04:24:50 PM
#4686   TIC TOC!! bleu22 08/08/17 03:52:54 PM
#4685   Power hour coming soon, hold E'M or fold E'M bleu22 08/08/17 02:57:16 PM
#4684   Conference call details are as follows: Scotttrader80 08/08/17 10:56:13 AM
#4683   Here comes DOLLARLAND again... glta declaes 08/08/17 10:18:28 AM
#4682   This company is disappointing. I expect the worse 10th_wonder 08/07/17 10:12:54 PM
#4681   Overselling or what? There's no reason for this bobbodom 08/07/17 03:13:33 PM
#4680   Nvax need to stop hitting my stop loses Santo 08/07/17 03:11:36 PM
#4679   Well support's at .97. Time to go back bobbodom 08/07/17 01:52:32 PM
#4678   Going much lower shorts are nailing this. Wormking777 08/07/17 11:15:09 AM
#4677   Thats what happens when companies disappoint. Until their Scotttrader80 08/07/17 10:35:49 AM
PostSubject